Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: A cohort study

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Walter, Jan ^a   Kuhn, Louise ^b   Kankasa, Chipepo ^c   Semrau, Katherine ^d   Sinkala, Moses ^e   Thea, Donald M ^d   Aldrovandi, Grace M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e Lusaka District Health Management Team   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CENTRAL AFRICAN REPUBLIC; CHILD DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MULTIPARA; OUTCOME ASSESSMENT; PERINATAL DRUG EXPOSURE; PLACENTAL TRANSFER; REPEATED DRUG DOSE; SINGLE DRUG DOSE; VIRUS LOAD; VIRUS TRANSMISSION; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS; MALE; NEWBORN; PARITY; PREGNANCY; PREGNANCY COMPLICATION; STATISTICAL MODEL; VIROLOGY; ZAMBIA;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOGISTIC MODELS; MALE; NEVIRAPINE; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD; ZAMBIA;

EID: 59349099743     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-172     Document Type: Article

References (17)

1. Jackson JB Musoke P Fleming T Guay LA Bagenda D Allen M Nakabiito C Sherman J Bakaki P Owor M Ducar C Deseyve M Mwatha A Emel L Duefield C Mirochnick M Fowler MG Mofenson L Miotti P Gigliotti M Bray D Mmiro F Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial Lancet 2003, 362:859-868. 10.1016/S0140-6736(03)14341-3 13678973
2. Arrive E Newell ML Ekouevi DK Chaix ML Thiebaut R Masquelier B Leroy V Perre PV Rouzioux C Dabis F Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: A meta-analysis Int J Epidemiol 2007 36 1009 1021 10.1093/ije/dym104 17533166
3. Lockman S Shapiro RL Smeaton LM Wester C Thior I Stevens L Chand F Makhema J Moffat C Asmelash A Ndase P Arimi P van Widenfelt E Mazhani L Novitsky V Lagakos S Essex M Response to antiretroviral therapy after a single, peripartum dose of nevirapine N Engl J Med 2007, 356:135-147. 10.1056/NEJMoa062876 17215531
4. Chi BH Sinkala M Stringer EM Cantrell RA Mtonga V Bulterys M Zulu I Kankasa C Wilfert C Weidle PJ Vermund SH Stringer JS Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine Aids 2007, 21:957-964. 10.1097/ QAD.0b013e32810996b2 17457089
5. Palmer S Boltz V Martinson N Maldarelli F Gray G McIntyre J Mellors J Morris L Coffin J Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission Proc Natl Acad Sci U S A 2006, 103:187094-7099. 1459023 16641095 10.1073/pnas.0602033103
6. Flys T Nissley DV Claasen CW Jones D Shi C Guay LA Musoke P Mmiro F Strathern JN Jackson JB Eshleman JR Eshleman SH Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012 J Infect Dis 2005, 192:24-29. 10.1086/430742 15942890
7. Loubser S Balfe P Sherman G Hammer S Kuhn L Morris L Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission Aids 2006, 20:995-1002. 10.1097/ 01.aids.0000222071.60620.1d 16603851
8. Martinson NA Ekouevi DK Dabis F Morris L Lupodwana P Tonwe-Gold B Dhlamini P Becquet R Steyn JG Leroy V Viho I Gray GE McIntyre JA Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Cote d'Ivoire J Acquir Immune Defic Syndr 2007, 45:206-209. 10.1097/QAI.0b013e318050d652 17438480
9. McConnell M Bakaki P Eure C Mubiru M Bagenda D Downing R Matovu F Thigpen MC Greenberg AE Fowler MG Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda J Acquir Immune Defic Syndr 2007, 46:291-296. 18167645
10. Eshleman SH Hoover DR Chen S Hudelson SE Guay LA Mwatha A Fiscus SA Mmiro F Musoke P Jackson JB Kumwenda N Taha T Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP J Infect Dis 2005, 192:30-36. 10.1086/430764 15942891
11. Kuhn L Aldrovandi GM Sinkala M Kankasa C Semrau K Mwiya M Kasonde P Scott N Vwalika C Walter J Bulterys M Tsai WY Thea DM Effects of early, abrupt weaning on HIV-free survival of children in Zambia N Engl J Med 2008, 359:130-141. 2577610 18525036 10.1056/NEJMoa073788
12. Thea DM Vwalika C Kasonde P Kankasa C Sinkala M Semrau K Shutes E Ayash C Tsai WY Aldrovandi G Kuhn L Issues in the design of a clinical trial with a behavioral intervention - the Zambia exclusive breast-feeding study Control Clin Trials 2004, 25:353-365. 10.1016/j.cct.2004.06.005 15296810
13. Walter J Mwiya M Scott N Kasonde P Sinkala M Kankasa C Kauchali S Aldrovandi GM Thea DM Kuhn L Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts J Infect Dis 2006, 194:1510-1518. 1773010 17083035 10.1086/508996
14. Weidle P Stringer J McConnell M Kiarie J Anekthananon T Jariyasethpong T Potter D Mutsotso W Borkowf C Bolu O Team TNRS Effectiveness of NNRTI-containing ART in Women Previously Exposed to a Single Dose of Nevirapine: A Multi-country Cohort Study [abstract] 16th Conference on Retroviruses and Opportunistic Infections Boston, MA 2008
15. Kuhn L Sinkala M Kankasa MP Kasonde P Thea DM Aldrovandi GM Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission J Acquir Immune Defic Syndr 2006, 42:260-262. 1773052 16760802 10.1097/01.qai.0000214820.26281.df
16. Flys TS McConnell MS Matovu F Church JD Bagenda D Khaki L Bakaki P Thigpen MC Eure C Fowler MG Eshleman SH Nevirapine Resistance in Women and Infants after First versus Repeated Use of Single-Dose Nevirapine for Prevention of HIV-1 Vertical Transmission J Infect Dis 2008, 198:465-469. 10.1086/590160 18582198
17. Dao H Mofenson LM Ekpini R Gilks CF Barnhart M Bolu O Shaffer N International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update Am J Obstet Gynecol 2007, 197:S42-55. 10.1016/j.ajog.2007.03.001 17825650